Scarica l'app Stockscreener
1.53
1.32%
0.02
Dopo l'orario di chiusura:
1.52
-0.01
-0.65%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché OPK Giù?
Forum
Previsione
Precedente Chiudi:
$1.51
Aprire:
$1.538
Volume 24 ore:
8.41M
Relative Volume:
3.18
Capitalizzazione di mercato:
$1.16B
Reddito:
$581.12M
Utile/perdita netta:
$-212.92M
Rapporto P/E:
-5.588
EPS:
-0.2738
Flusso di cassa netto:
$-174.22M
1 W Prestazione:
+7.75%
1M Prestazione:
+18.60%
6M Prestazione:
+18.60%
1 anno Prestazione:
+15.91%
Intervallo 1D:
$1.50
$1.6051
Intervallo di 1 settimana:
$1.355
$1.6051
Portata 52W:
$0.9769
$1.6051
Opko Health Inc Stock (OPK) Company Profile
Nome
Opko Health Inc
Settore
Industria
Telefono
305-575-4181
Indirizzo
4400 BISCAYNE BLVD., MIAMI, FL
Compare OPK vs TMO, DHR, IDXX, A, NTRA
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OPK
Opko Health Inc
|
1.53 | 1.14B | 581.12M | -212.92M | -174.22M | -0.2738 |
TMO
Thermo Fisher Scientific Inc
|
513.03 | 187.95B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
196.19 | 136.75B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
551.50 | 43.78B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
136.01 | 38.27B | 7.23B | 1.41B | 1.09B | 4.979 |
NTRA
Natera Inc
|
261.91 | 37.34B | 2.50B | -226.32M | 71.51M | -1.6412 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-20 | Iniziato | JP Morgan | Neutral |
| 2025-10-31 | Downgrade | Jefferies | Buy → Hold |
| 2025-04-25 | Iniziato | JP Morgan | Neutral |
| 2023-06-29 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2022-12-15 | Iniziato | H.C. Wainwright | Buy |
| 2022-01-24 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2021-06-21 | Iniziato | Ladenburg Thalmann | Buy |
| 2019-11-25 | Iniziato | Piper Jaffray | Overweight |
| 2018-03-02 | Downgrade | JP Morgan | Neutral → Underweight |
| 2017-09-14 | Downgrade | JP Morgan | Overweight → Neutral |
| 2016-06-21 | Reiterato | Standpoint Research | Buy |
| 2016-06-03 | Iniziato | Standpoint Research | Buy |
| 2016-03-31 | Reiterato | Barrington Research | Outperform |
| 2015-10-16 | Iniziato | JP Morgan | Overweight |
| 2015-09-11 | Downgrade | Jefferies | Buy → Hold |
| 2015-03-03 | Downgrade | Oppenheimer | Outperform → Perform |
| 2014-05-12 | Reiterato | Oppenheimer | Outperform |
| 2014-03-14 | Iniziato | Oppenheimer | Outperform |
| 2013-11-13 | Reiterato | Ladenburg Thalmann | Buy |
| 2013-05-30 | Reiterato | Ladenburg Thalmann | Buy |
| 2012-10-22 | Iniziato | Barrington Research | Outperform |
| 2011-12-01 | Reiterato | Ladenburg Thalmann | Buy |
| 2011-07-14 | Iniziato | Ladenburg Thalmann | Buy |
Mostra tutto
Opko Health Inc Borsa (OPK) Ultime notizie
Price to book forward of OPKO Health, Inc. – FWB:XCY - TradingView
Enterprise value to EBIT forward of Opko Health, Inc. – NASDAQ:OPK - TradingView
Opko Health stock hits 52-week high at 1.6 USD By Investing.com - Investing.com Canada
Enterprise value to EBIT forward of OPKO Health, Inc. – FWB:XCY - TradingView
OPKO Health, Inc. Actuals & Estimates (NASDAQ:OPK) - TradingView
OPKO Health, Inc. Actuals & Estimates (FWB:XCY) - TradingView
OPKO Health, Inc. Actuals & Estimates (TASE:OPK) - TradingView
OPK Forecast — Price Target — Prediction for 2027 - TradingView
OPKO Health (OPK) Stock Could Be 57% Undervalued As Margin Recovery Comes Into Focus - Sahm
OPKO Health Inc (OPK) Institutional Confidence - TradingKey
OPKO Health Inc (OPK) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
OPKO Health Inc (OPK) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Form 4 Opko Health For: 22 June By Investing.com - Investing.com Nigeria
Director at OPKO (NASDAQ: OPK) receives grant of 60,000 stock options - Stock Titan
OPKO Health (OPK) director receives 30,000-share stock option award at $1.42 - Stock Titan
Opko Health (OPK) director Roger Medel receives 30,000 stock options grant - Stock Titan
Opko Health (OPK) director awarded 30,000 stock options at $1.42 strike - Stock Titan
OPKO HEALTH (OPK) director receives 80,000-share stock option grant - Stock Titan
OPKO Health (OPK) director receives stock options for 30,000 shares - Stock Titan
OPKO Health (OPK) up 17.1% since last earnings report: Can it continue? - MSN
Opko Health Shareholders Back Board, Equity and Auditors - The Globe and Mail
Opko Health shareholders elect board and approve key proposals at annual meeting - Investing.com
OPKO Health (OPK) AGM 2026 Summary - Quartr
OPK: All proposals passed, with robust pipeline progress and $98M remaining for share repurchases - TradingView
OPKO Health Inc (OPK) Valuation: PE, PB & Fair Value Analysis - TradingKey
OPKO Health Inc (OPK) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
OPKO Health Inc (OPK) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
OPKO Health Inc (OPK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
OPKO Health Inc (OPK) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
OPKO Health Inc (OPK) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Piper Sandler Sticks to Their Buy Rating for Opko Health (OPK) - The Globe and Mail
OPKO Health (OPK) Stock Could Be 58.8% Undervalued After OPK8801001 Preclinical Update - Sahm
OPKO presents preclinical data on acromegaly drug candidate By Investing.com - Investing.com Australia
OPKO presents preclinical data on acromegaly drug candidate - Investing.com
Preclinical Data for OPKO Biologics' OPK8801001 in Acromegaly Presented at ENDO 2026 - The Manila Times
OPKO Health (OPK) price target increased by 11.18% to 3.86 - MSN
Discover 3 Promising Penny Stocks With Market Caps Over $20M - simplywall.st
Assessing OPKO Health (OPK) Valuation After Expanded Nicoya RAYALDEE Partnership In Greater China - Yahoo Finance
Here's why you should retain OPK stock in your portfolio for now - MSN
How Investors May Respond To OPKO Health (OPK) Boosting Its Nicoya Stake And RAYALDEE Milestones - Yahoo Finance
OPKO Deepens Nicoya Alliance As RAYALDEE China Prospects Draw Focus - Sahm
OPKO Health (OPK) Amends Partnership With Nicoya Therapeutics to Gain Equity Stake - Insider Monkey
OPK Technical Analysis | Trend, Signals & Chart Patterns | OPKO HEALTH INC (NASDAQ:OPK) - ChartMill
OPKO Health (OPK) Jefferies Global Healthcare Conference 2026 Summary - Quartr
OPK Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
OPKO Health Inc stock (US68375N1037): shares trade steady after recent earnings while valuation stay - AD HOC NEWS
Opko Health Inc Azioni (OPK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Opko Health Inc Azioni (OPK) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 21 '25 |
Buy |
1.33 |
580,000 |
768,807 |
216,706,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 20 '25 |
Buy |
1.33 |
580,000 |
771,328 |
216,126,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 19 '25 |
Buy |
1.31 |
580,000 |
759,115 |
215,546,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 18 '25 |
Buy |
1.27 |
533,300 |
678,906 |
214,966,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Oct 31 '25 |
Buy |
1.42 |
150,000 |
213,435 |
214,386,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Aug 08 '25 |
Buy |
1.32 |
675,000 |
891,000 |
214,676,448 |
1.76%
0.62%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):